Results 201 to 210 of about 80,718 (256)

Conjugate Vaccines Targeting Tumor-Associated Carbohydrate Antigens. [PDF]

open access: yesVaccines (Basel)
Rosenglick N   +4 more
europepmc   +1 more source

Redefining functional high‐risk multiple myeloma in the context of upfront quadruplet therapy and autologous stem cell transplantation

open access: yesCancer, Volume 132, Issue 14, 15 July 2026.
Abstract Background Functional high‐risk (FHR) multiple myeloma (MM) was historically defined as progression within 18 months of starting therapy, with expected subsequent overall survival (OS) <2 years. The optimal definition of FHR in the era of combined quadruplet therapy (QUAD) + autologous stem cell transplantation (ASCT) is unknown.
Gayathri Ravi   +9 more
wiley   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, Volume 32, Issue 26, 11 July 2026.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer. [PDF]

open access: yesJ Immunother Cancer
Liu Y   +24 more
europepmc   +1 more source

Incorporation of Tn Antigen Mimetics into the MUC1

open access: yes, 2023
Carmen Breton   +4 more
openaire   +2 more sources

Fluorinated carbohydrate-based vaccines. [PDF]

open access: yesChem Sci
Chikunova E   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy